Real-time enrollment status for this melanoma clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 7:57 AM UTC
| NCT Number | NCT05136196 |
| Recruiting Status | Recruiting |
| Condition | Melanoma |
| Phase | PHASE2 |
| Target Enrollment | 150 participants |
| Active Locations | 230 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | October 14, 2026 (2 days ago) |
As of October 16, 2026: Clinical trial NCT05136196 is currently recruiting participants. This phase2 study for melanoma is actively seeking new participants at 230 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05136196 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 230 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05136196 was last updated 2 days ago (October 14, 2026). HelloStudys verifies this status automatically.